Skip to content

Anti-smallpox globulin

CAS -
50

Safety score · 0–100

Moderate

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

A biological preparation derived from human blood plasma, historically used as a smallpox therapeutic. It has no established role or benefit in cosmetic skincare.

Anti-smallpox Globulin is a human blood-derived immunoglobulin preparation containing antibodies against the smallpox (variola) virus. It was developed as a post-exposure prophylactic or therapeutic for smallpox. It is a biological material of human origin, requiring careful screening for blood-borne pathogens. In cosmetic formulations, its use is highly unusual and safety data for topical application are essentially nonexistent.

Skin benefits

  • No established skin benefits in cosmetic context

Known concerns

  • Risk of blood-borne pathogen transmission (viruses, prions)
  • Potential immunogenic reactions
  • No safety data for topical cosmetic use
  • Biologic of human origin — significant regulatory concern

References

EU

EU CosIng database

European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.

Check your shelf

Find Anti-smallpox globulin in your products.

Scan any cosmetic product with LuxSense to see if it contains Anti-smallpox globulin and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.